Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics
The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Cannabidiol (CBD) is an abundant non‐psychoactive phytocannabinoid in cannabis
extracts which has high affinity on a series of receptors, including Type 1 cannabinoid …
extracts which has high affinity on a series of receptors, including Type 1 cannabinoid …
Cannabinoids block cellular entry of SARS-CoV-2 and the emerging variants
As a complement to vaccines, small-molecule therapeutic agents are needed to treat or
prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and …
prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and …
Natural products, alone or in combination with FDA-approved drugs, to treat COVID-19 and lung cancer
L Yang, Z Wang - Biomedicines, 2021 - mdpi.com
As a public health emergency of international concern, the highly contagious coronavirus
disease 2019 (COVID-19) pandemic has been identified as a severe threat to the lives of …
disease 2019 (COVID-19) pandemic has been identified as a severe threat to the lives of …
Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling …
C Corpetti, A Del Re, L Seguella, I Palenca… - Phytotherapy …, 2021 - Wiley Online Library
Given the abundancy of angiotensin converting enzyme 2 (ACE‐2) receptors density,
beyond the lung, the intestine is considered as an alternative site of infection and replication …
beyond the lung, the intestine is considered as an alternative site of infection and replication …
Anti-inflammatory and antiviral effects of cannabinoids in inhibiting and preventing SARS-CoV-2 infection
M Janecki, M Graczyk, AA Lewandowska… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for
new options for both causal treatment and mitigation of its symptoms. Scientists and …
new options for both causal treatment and mitigation of its symptoms. Scientists and …
Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review
Background The COVID-19 pandemic is affecting mental health and substance use (MHSU)
issues worldwide. The purpose of this study was to characterize the literature on changes in …
issues worldwide. The purpose of this study was to characterize the literature on changes in …
A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
RL Chapman, SV Andurkar - Medicinal Chemistry Research, 2022 - Springer
During the COVID-19 pandemic lasting now for well more than a year, nearly 247 million
cases have been diagnosed and over 5 million deaths have been recorded worldwide as of …
cases have been diagnosed and over 5 million deaths have been recorded worldwide as of …
Cannabis sativa: 2023-Outbreak and Re-emergence of Nipah virus (NiV) in India: Role of Hemp oil
RB Malabadi, KP Kolkar… - GSC Biological and …, 2023 - gsconlinepress.com
This review paper highlights and updates the outbreak of Nipah virus (NiV), an emerging
zoonotic bat borne virus that can cause severe respiratory illness and deadly encephalitis in …
zoonotic bat borne virus that can cause severe respiratory illness and deadly encephalitis in …
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …
garnered increasing attention for its diverse therapeutic potential. This comprehensive …